3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
2
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Ovarian Neoplasms
55
Small Cell Lung Carcinoma
39
Lung Neoplasms
30
Carcinoma, Ovarian Epithelial
29
Neuroblastoma
25
Fallopian Tube Neoplasms
23
Uterine Cervical Neoplasms
18
Neoplasms
18
Leukemia
18
Leukemia, Myeloid, Acute
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Sarcoma
10
Lymphoma
10
Brain Neoplasms
9
Recurrence
8
Carcinoma, Non-Small-Cell Lung
8
Unspecified Adult Solid Tumor, Protocol Specific
7
Neoplasm Metastasis
7
Myelodysplastic Syndromes
7
Burkitt Lymphoma
7
Blast Crisis
7
Neuroectodermal Tumors, Primitive, Peripheral
6
Lymphoma, Non-Hodgkin
6
Lymphoma, Large B-Cell, Diffuse
6
Lymphoma, Follicular
6
Leukemia, Myelomonocytic, Chronic
6
Leukemia, Myelomonocytic, Acute
6
Leukemia, Monocytic, Acute
6
Leukemia, Megakaryoblastic, Acute
6
Leukemia, Erythroblastic, Acute
6
Interventions
pegylated granulocyte colony-stimulating factor
1
devimistat
1
Topotecan
1
Sunitinib
1
Sirolimus
1
Simvastatin
1
Radiotherapy, Image-Guided
1
Nivolumab
1
Methotrexate
1
Ifosfamide
1
Hydroxychloroquine
1
Granulocyte Colony-Stimulating Factor
1
Epirubicin
1
Doxorubicin
1
Dacarbazine
1
Cyclophosphamide
1
Crizotinib
1
Cisplatin
1
ARQ 197
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Sarcoma, Clear Cell
×
Topotecan
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled